hotspot -WSS

hotspot

author：hotspot 2025-10-01 23:02:55 - browse：6929

Seng Cheng has been working in gene therapy for nearly as long as gene therapy has been a field. As a young scientist in the early 1990s, he was part of one of three teams racing to develop a gene therapy for cystic fibrosis, a high-profile effort that resulted in national headlines, prestigious publications, and zero patients cured.

So he’s seen the field’s highs and lows. Lately, there have been a lot of both, including at Pfizer, the company Cheng called home until this summer. The pharma brought three potentially powerful gene therapies for muscular dystrophy and hemophilia into late-stage trials but, in January, chose to abandon a large portfolio of early stage candidates that relied on the same technology: adeno-associated viruses, or AAVs, a group of small bugs that scientists spent two decades taming into a gene shipping system.

The move seemed emblematic. Across the industry, AAV companies have been struggling, either shelving programs or stopping work altogether, while investors shuttled money toward new technologies such as CRISPR and its various permutations. Longtime researchers feared promising drugs, particularly for ultra-rare diseases, might get lost in the shuffle.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： PBM executives asked to testify by House panel

hotspot

WSS

Affordable Connectivity Program vital to health care, experts say

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Mass General totes up its waste in a move to tackle climate change

Lawmakers grill UnitedHealth CEO on Change cyberattack

Can gargling with Listerine treat gonorrhea of the mouth?

explore

hotspot

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Texas Department of Public Safety speaks out on migrant abuse allegations

Walensky prepares to leave CDC — and Congress — behind

Black vets could get higher VA benefits if race not used in lung test

At least 13 dead in Texas as scorching temps continue

7 more heat

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Deliver public health messages at the right time

Continuity nursing helped my family in our darkest PICU moments

Hospitals struggle to profit from CAR

hotspot

I learned firsthand about improving diversity in clinical trials

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Most antidepressants don't work on kids, teens, study finds

Judge rejects Trump's request to move Stormy Daniels hush

The effects of a landmark ruling on DNA ownership are becoming clearer

Stanford president's case begs question: Who takes blame?

hotspot

explore

knowledge

hotspot